The Leukemia, Lymphoma and Multiple Myeloma Program at UC Davis Cancer Center is the largest and most comprehensive program of its kind in inland Northern California. It provides the most advanced methods of diagnosis and treatment possible, including new therapies that often aren't available at community hospitals.

The physicians in our Leukemia, Lymphoma and Multiple Myeloma Program have extensive experience treating both common and uncommon cancers of the blood, bone marrow and lymphatic system. This includes the more than 40 subtypes of lymphoma, as well as such rare malignancies as hairy-cell leukemia.

Our physician-scientists are also at the forefront of research to develop and test new drugs to combat this family of cancers, ensuring that new treatments developed in the lab move quickly to the clinic for the immediate benefit of our patients.

Our excellence in cancer care is reflected in our designation by the National Cancer Institute, the nation’s top cancer organization. Only 60 other cancer centers nationwide have successfully competed for this designation, a mark of the highest standards and achievements in cancer research and treatment.

The UC Davis Cancer Center's Leukemia, Lymphoma and Multiple Myeloma Treatment Program is staffed by specialists in:

• hematology and oncology 
• radiation oncology 
• pathology 
• stem cell transplantation 
• nuclear medicine 
• radiology 

This multidisciplinary team of top academic physicians is accustomed to developing and carrying out complex, cutting-edge, rigorous treatment regimens designed to offer each patient the best chance for a cure.

Treatments may include:

• radiation
• radioimmunotherapy (nuclear medicine)
• chemotherapy
• molecular-targeted therapy
• stem cell transplantation

Throughout treatment, our patients have access to the latest technology, including an in-house cytogenetics lab that allows us to study chromosomes in order to provide individualized treatment based on a person's genes. In our bone marrow lab, each specimen is independently reviewed by two specialists, one in pathology and one in hematology and oncology.

UC Davis Cancer Center has one of the nation's largest clinical trials programs, offering patients access to the newest drugs and treatments before they become widely available. The Cancer Center participates in two National Cancer Institute-sponsored adult clinical trials groups: the Southwest Oncology Group, made up of 283 leading cancer treatment and research institutions throughout North America, and the Radiation Therapy Oncology Group, comprising 250 centers. In addition, our physicians conduct novel clinical trials through the California Cancer Consortium, a research collaboration that also includes the City of Hope National Medical Center in Duarte, Calif., and the University of Southern California in Los Angeles.

At our Roseville Infusion Center and our affiliate cancer centers in Marysville and Merced, many of our patients are able to receive some or all of their treatment closer to home. At all locations, top academic physicians at UC Davis Cancer Center closely monitor and guide each patient's care.

The UC Davis Leukemia, Lymphoma and Multiple Myeloma Program is dedicated to caring for the whole patient. We offer:

• a leukemia and lymphoma support group
• psychosocial counseling
• patient education, classes, lectures and newsletter
• discounts on gentle yoga classes and massage therapy
• a Cancer Resource Center

Hematology/Oncology

Carol M. Richman, M.D.
Professor of Internal Medicine, Hematology and Oncology
Director, Bone Marrow Transplant Program

Joseph M. Tuscano, M.D., Ph.D.
Associate Professor of Internal Medicine, Hematology and Oncology

Jeanna Welborn, M.D.
Professor of Medicine, Pathology and Laboratory Medicine
Medical Director, Bone Marrow Laboratory, Cytogenetics Laboratory  and Therapeutic Apheresis

Ted Wun, M.D.
Vice Chief of Hematology and Oncology
Director of CTSC Clinical Research Center
Professor of Medicine, Pathology and Laboratory Medicine

Radiation Oncology

Janice K. Ryu, M.D.
Professor of Radiation Oncology

Radioimmunotherapy

Robert O'Donnell, M.D., Ph.D.
Professor of Medicine

Leukemia, Lymphoma and Multiple Myeloma Program
UC Davis Cancer Center
4501 X St.
Sacramento, CA 95817

New patient appointments: (916) 703-5210 or (800) 362-5566

Affiliate centers

Infusion Center, Roseville Specialty Clinic
UC Davis Medical Group
2261 Douglas Blvd.
Roseville, CA 95661
(916) 783-7109, option 3

Fremont-Rideout Cancer Center
618 5th St.
Marysville, CA 95901
(530) 749-4400

Mercy UC Davis Cancer Center
3850 G St.
Merced, CA 95340
(209) 386-6000

Updated 12/2007.